Access to 68Gallium-PSMA-11 PET Imaging for Prostate Cancer Detection and Treatment Planning

Sponsor: University of California, San Francisco

Expanded Access
Approved for Marketing
Sponsor score: 40
Inactive

ClinicalTrials ID:NCT04377152

Provider View

This program offers eligible patients access to a special imaging test called 68Ga-PSMA-11 PET, which helps in detecting and locating prostate cancer to guide treatment decisions.

Patient Parameters

Program Overview

This program allows patients to use a special imaging test called 68Ga-PSMA-11 PET. This test helps doctors find and pinpoint prostate cancer, which can be important for planning both initial and follow-up treatments.

Eligibility Criteria

Inclusion Criteria

  • Must be 18 years or older.
  • Must have a confirmed diagnosis of prostate adenocarcinoma, either through lab tests or a biopsy.
  • Must have concerns about cancer spreading in one of these situations:
    • When first diagnosed with intermediate to high risk prostate cancer.
    • If cancer returns after initial treatment.
  • Must be able to understand and sign a consent form agreeing to participate.

Exclusion Criteria

  • If you are unlikely to follow the study procedures or requirements, or if the study doctor thinks you are not suitable for participation.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.